Features of the course of arterial hypertension combined with hyperurikemia
pdf (Українська)

Keywords

arterial hypertension, uric acid, hyperuricemia, lipid profile, metabolic syndrome

How to Cite

Skybchyk , V., Virna , M., Zaremba , O., & Rak , N. (2023). Features of the course of arterial hypertension combined with hyperurikemia. The Practitioner, (1), 57-61. Retrieved from https://plr.com.ua/index.php/journal/article/view/755

Abstract

The work is devoted to studing the influence of uric acid on the course of arterial hypertension. Purpose. To study the gender and sex characteristics of the state of lipid, carbohydrate, fat metabolism in patients with arterial hypertension depending on the level of uric acid. Materials and methods. 98 patients (42 men and 54 women) with stage II hypertension of 1-3 degrees were examined, the average age of which was 54.6±8.1 years. Patients were divided into 2 groups. Group I (n=59) — patients with hypertension and hyperuricemia, Group II (n=39) — patients with hypertension without hyperuricemia. The control group consisted of 20 practically healthy persons without signs of hypertension, representative in terms of age and sex. The results. It has been found that the level of uric acid in the examined patients exceeded the indicators of practically healthy persons in
women by 49.1% (р˂0.01), and in men by 20.8%. The highest level of uric acid was observed at the age under 60 years (р˂0.05). An increase in uric acid concentration in patients with hypertension is associated with an increase in TG, glycated hemoglobin and a decrease in HDL. Conclusions. In patients with hypertension, hyperuricemia is significantly more common in women than in men and at the age under 60 years. In the case of a combination of hypertension with hyperuricemia, more pronounced disorders of lipid, fat, and carbohydrate metabolism have been established.

pdf (Українська)

References

1. 2018 ESC/ESH Guidelines for the management of arterial hypertension. B Williams. Kardiologia Polska. 2019:71-159.
2. 2020 American College of Rheumatology Guideline for the Management of Gout. JD FitzGerald. Arthritis Care & Research. 2020;72(6):744-760.
3. Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. RJ Johnson. American Journal of Kidney Diseases. 2018;71(6):851-865. DOI:10.1053/j.ajkd.2017.12.009.
4. Міщенко ЛА. Зв’язок гіперурикемії з ураженням органів-мішеней у хворих на гіпертонічну хворобу. Кардiологія: від науки до практики. 2015;2(15):41-51.
5. Kanbay M, Kuwabara M. The causality between the serum uric acid level and stroke. Hypertension Research. 2020;43(4):354-356. DOI: 10.1038/s41440-019-0346-z.
6. Age-differential association between serum uric acid and incident hypertension. SW Lee. Hypertension Research. 2018;42(3):428-437. DOI:10.1038/s41440-018-0168-4.
7. Крилова АС, Дубкова АГ, Цимбалюк ТС. Диференційований підхід до уратзнижувальної терапії подагри залежно від віку, статі та супутньої патології. Український ревматологічний журнал. 2021;4(86):32-39.
8. Несукай ОГ. Артеріальна гіпертензія та гіперурикемія: думка кардіолога. Медична газета «Здоров’я України 21 сторіччя». 2019;11(456):3.
9. Ndrepepa G, Cassese S, Braun S et al. A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. Nutr Metab Cardiovasc Dis. 2013;23(12):1195-1201.
10. Yamanaka H. Gout and hyperuricemia in young people. Curr. Opin. Rheumatol. 2011;23(2):156-160.
11. Lipoprotein subfractions partly mediate the association between serum uric acid and coronary artery disease / Y Zhang, RX Xu, S Li [et al.]. Clin. Chim. Acta. 2015;441:109-114.
12. Elevated serum uric acid is associated with vascular inflammation but not coronary artery calcification in the healthy octogenarians: the Brazilian study on healthy aging / R Malik, EC Aneni, S Shahrayar [et al.]. Aging. Clin. Exp. Res. 2016;28(2):359-362.
13. Ogbera AO, Azenabor AO. Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol. Metab. Syndr. 2010;2:24.
14. Yang T, Chu CH, Bai CH et al. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis. 2012;220(2):525-531.
15. Tomiyama H, Higashi Y, Takase B, et al. Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am. J. Hypertens. 2011;24(7):770-774.

Downloads

Download data is not yet available.